title: Stabilization of activation induced cytidine deaminase by bortezomib does not confer increased drug target mutation frequency.
authors.affiliation: Department of Genetics, Cell Biology and Development.
authors.forename: Holly A F
authors.initials: HA
authors.lastname: Stessman
authors.forename: Aatif
authors.initials: A
authors.lastname: Mansoor
authors.forename: Michael A
authors.initials: MA
authors.lastname: Linden
authors.forename: Brian
authors.initials: B
authors.lastname: Van Ness
authors.forename: Linda B
authors.initials: LB
authors.lastname: Baughn
mesh_terms: D001897:Boronic Acids / Q000494:pharmacology*; D000069286:Bortezomib; D002051:Burkitt Lymphoma / Q000201:enzymology / Q000235:genetics; D045744:Cell Line, Tumor; D003564:Cytidine Deaminase / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism*; D019008:Drug Resistance, Neoplasm / Q000235:genetics; D004789:Enzyme Activation / Q000187:drug effects; D006801:Humans; D020128:Inhibitory Concentration 50; D009154:Mutation / Q000187:drug effects*; D059645:Mutation Rate; D011719:Pyrazines / Q000494:pharmacology*
chemical_list: D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib; D003564:Cytidine Deaminase